Parkinson's disease (PD) is a chronic and progressive neurodegenerative disease that affects ~7 million people worldwide, without any cure to date; however, it can be symptomatically treated. In this vein, innovative technologies can be used for the objective assessment of clinical symptoms and to provide supportive therapies at home. The present work explores the processes and the outcomes of the i-PROGNOSIS (www.i-prognosis.eu) intervention deployment in three PD clinical centres (Greece, UK, and Germany). For that purpose, 36 PD patients were recruited to voluntarily participate in the i-PROGNOSIS feasibility study, spread across the three different countries. The PD patients interacted with the i-PROGNOSIS system for up-to-three months, mainly within the clinical environment, using the provided iPrognosis Games in dedicated gaming stations that were setup in the corresponding clinical centres. Overall, the results show that the iPrognosis Games were positively evaluated by medical experts. Moreover, based on the collected feedback, the iPrognosis Games have achieved their main goals of providing an innovative, objective and usable system for the monitoring of early PD (motor and non-motor) symptomatology, by providing tools for complementing existing clinical interventions for the improvement of PD patients' quality of life.
